| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c90310252cb8283cf96f3dc8eb0fe008 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
| filingDate |
2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65423ceaa9bddf95755332743d770f43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63fa507c7f5edd549d072fa03a202c06 |
| publicationDate |
2006-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006160783-A1 |
| titleOfInvention |
Novel omeprazole forms and related methods |
| abstract |
The invention provides: (1) novel sodium-containing omeprazole salts formed by the reaction of omeprazole and a sodium source in a crystallization solvent; (2) novel zinc-containing omeprazole salts formed by the reaction of omeprazole and a zinc source in a crystallization solvent, including salts formed by the recrystallization of a zinc salt in a reaction mixture comprising a sodium-containing omeprazole salt and a crystallization solvent; and (3) methods of treatment which use the novel salts to treat or prevent gastric acid-related diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012142738-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11564910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045450-B2 |
| priorityDate |
2004-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |